100+ beauty industry executives, from strategic buyers, financial buyers and independent beauty brands, all looking for their next investment, acquisition or business partnering opportunity.
Developing BioAg products brings with it various demands and challenges - for example complying with regulation, managing resistance, formulation compatibility of ingredients and scale up challenges.Agbio Innovate USA aims to address regulatory hurdles that directly impact the biopesticide and biostimulant sector in North America as well as explores formulation technology and R&D advances with insight from industry leaders.We also address the exciting rise of AgTech and the future of vertical farming.With application technology advancing, formulations and products need to adapt to meet the future needs of farmers and growers.Direct answers to your regulatory challenges with unparalleled guidance sessions on the EPA's regulatory requirements under FIFRA that are applicable to biopesticides and biostimulantsCreate BioAg commercialization opportunities by building R&D and investment partnerships - network with 80+ industry representatives including ABM, Bayer, BioConsortia, Marrone Bio Innovations and many more3Bar Biologics and Global BioAg Linkages share how to build an ecosystem where companies are working jointly together, each bringing their unique skill set to solve problems and create value- bringing you measurable results for success Accelerate BioAg product development by using advanced technologies – Discover insight from Terramera on how machine learning and artificial intelligence are being used to analyze and interpret data across multiple development platforms
The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin? Introducing the Skin Microbiome Congress.Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry.Join 250+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field.Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler applicationCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiomeConsumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiomeClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeuticsCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed productsRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic productWith an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!
SLS Hotel, 465 S La Cienega Blvd, Los Angeles, CA, USA
150+ beauty industry executives, from strategic buyers, financial buyers and independent beauty brands, all looking for their next investment, acquisition or business partnering opportunity.
The Global Probiotics in Animal Feed Market is poised to grow at a CAGR of around 7.9% over the next decade to reach approximately $6.37 billion by 2025.The European Animal Microbiome Congress brings together leading veterinary researchers, innovative biotechnology companies, feed and strain manufacturers, animal breeders and producers, animal pharmaceutical companies, regulatory bodies, and cutting-edge solution providers to showcase the latest commercially viable research focusing on manipulating the animal microbiome, form successful product development strategies, and facilitate collaborations and business partnering. Techniques and products that manipulate the animal microbiome are set to be the next frontier in superior disease therapeutics, diagnostics, and nutrition in livestock, companion animals, and aquaculture. This conference will showcase unpublished data, new technologies, and translational case studies presented by leading academic and industry experts.
The Animal Microbiome Congress is a place for veterinary researchers, animal breeders and producers, feed and strain manufacturers, pharmaceutical and nutrition companies, government and regulatory bodies and ground-breaking solution providers to discuss ideas, form collaborations and identify strategies for development to manipulate the animal microbiome.
Join the first ever conference connecting human biotechs with the animal health industry.
Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.
The Artificial Intelligence: Transforming Pharma Congress will discuss AI's potential for more efficiently discovering medical trends and efficacious therapeutics and also for streamlining the development phase. We'll be sharing case studies and analysis into current AI partnerships and collaborations.
Welcome to the 3rd Annual North America Microbiome Congress!The 3rd Annual North America Microbiome Congress in San Diego, by Kisaco Research, has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require an insight into the latest microbiome research, clinical trials and collaborative partnerships.With a focus on 5 microbiome niches such as the gut, lung, oral, skin and vaginal- we invite you to join us for 3 days of intense learning, mind-sharing and networking opportunities designed to encourage meaningful connections. In addition, we will be hosting poster sessions for PhD students to provide opportunities for all scientists to learn about state-of-the-art research methods and clinical protocols for conducting microbiome work.Meet and learn from industry leadersConsider the practical aspects of promoting effective partnershipsLearn from the latest unpublished dataNetwork with top academics and clinicians in the field
